Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.10.0.1
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Schedule of Effect of Adoption of ASC Topic 606 on Condensed Consolidated Balance Sheet and Statement of Operations

The following tables present the effect of the adoption of ASC Topic 606 on our condensed consolidated balance sheet and revenue as of and for the nine months ended September 30, 2018:

 

    September 30, 2018  
          (unaudited)        
    As reported     Balances without Adoption of ASC 606     Effect of Change
Higher/(Lower) 		 
Accounts receivable, net   $ 8,640     $ 7,963     $ 677  
Accumulated deficit     (137,452 )     (139,952 )     (2,500 )

 

Revenue:                  
    For the Nine Months Ended September 30, 2018  
          (unaudited)        
    As reported     Balances without Adoption of ASC 606     Effect of Change
Higher/(Lower) 		 
Revenue, net   $ 16,062     $ 14,792     $ 1,270  

Schedule of Other Current Assets

Other current assets consisted of the following as of September 30, 2018 and December 31, 2017:

 

    September 30, 2018     December 31, 2017  
      (unaudited)          
                 
Indemnification asset   $ 875     $ 875  
Prepaid assets     662       266  
Other     66       31  
    $ 1,603     $ 1,172  

Schedule of Weighted Average Number of Shares

A reconciliation of the number of shares of common stock used in the calculation of basic and diluted loss per share for the three- and nine-month periods ended September 30, 2018 and 2017 is as follows:

 

    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2018     2017     2018     2017  
    (unaudited)  
                         
Basic weighted average number of common shares     28,215       22,028       28,002       12,022  
Potential dilutive effect of stock-based awards     -       -       -       -  
Diluted weighted average number of common shares     28,215       22,028       28,002       12,022  

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following outstanding stock-based instruments were excluded from the computation of the effect of dilutive securities on loss per share for the following periods presented because they would have been anti-dilutive:

 

 

    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2018     2017     2018     2017  
    (unaudited)  
                         
Options     2,256       1,496       2,256       1,496  
Stock-settled stock appreciation rights (SARs)     59       84       59       84  
Restricted stock units (RSUs)     220       68       220       68  
Warrants     13,542       15,267       13,542       15,267  
      16,077       16,915       16,077       16,915